Osteopontin is Increased in the Cerebrospinal Fluid of Patients with Alzheimer's Disease and Its Levels Correlate with Cognitive Decline

被引:96
作者
Comi, Cristoforo [1 ,2 ,5 ]
Carecchio, Miryam [1 ]
Chiocchetti, Annalisa [3 ,5 ]
Nicola, Stefania [3 ,5 ]
Galimberti, Daniela [4 ]
Fenoglio, Chiara [4 ]
Cappellano, Giuseppe [3 ,5 ]
Monaco, Francesco [1 ,5 ]
Scarpini, Elio [4 ]
Dianzani, Umberto [3 ,5 ]
机构
[1] A Avogadro Univ Eastern Piedmont, Dept Neurol, Maggiore Hosp, Novara, Italy
[2] Neurorehabil Inst ML Novarese, Moncrivello, VC, Italy
[3] A Avogadro Univ Eastern Piedmont, Dept Med Sci, Maggiore Hosp, Novara, Italy
[4] Univ Milan, Dino Ferrari Ctr, Dept Neurol Sci, IRCCS Osped Maggiore Policlin, Milan, Italy
[5] A Avogadro Univ Eastern Piedmont, IRCAD, Novara, Italy
关键词
Disease progression; early Alzheimer's disease; Eta-1; microglia; neuroinflammation; FRONTOTEMPORAL LOBAR DEGENERATION; PARKINSONS-DISEASE; PROGRESSION; IMPAIRMENT; INFLAMMATION; BIOMARKERS; EXPRESSION; CRITERIA; BRAIN;
D O I
10.3233/JAD-2010-1309
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Inflammation is believed to play a role in Alzheimer's disease (AD). Osteopontin (OPN) is a molecule involved in macrophage recruitment and activation and implicated in neurodegeneration. In order to elucidate the role of OPN in AD, we evaluated its levels in serum and cerebrospinal fluid (CSF) of 67 AD patients, 46 frontotemporal dementia (FTD) patients, and 69 controls. We found that OPN levels: i) are significantly increased in the CSF of AD patients; ii) correlate with MMSE score; and iii) are higher in the early disease phases (<= 2 years). These findings support a role of OPN in AD pathogenesis.
引用
收藏
页码:1143 / 1148
页数:6
相关论文
共 21 条
[1]   CSF biomarkers for mild cognitive impairment and early Alzheimer's disease [J].
Andreasen, N ;
Blennow, K .
CLINICAL NEUROLOGY AND NEUROSURGERY, 2005, 107 (03) :165-173
[2]   The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease [J].
Chabas, D ;
Baranzini, SE ;
Mitchell, D ;
Bernard, CCA ;
Rittling, SR ;
Denhardt, DT ;
Sobel, RA ;
Lock, C ;
Karpuj, M ;
Pedotti, R ;
Heller, R ;
Oksenberg, JR ;
Steinman, L .
SCIENCE, 2001, 294 (5547) :1731-1735
[3]   Osteopontin gene haplotypes correlate with multiple sclerosis development and progression [J].
Chiocchetti, A ;
Comi, C ;
Indelicato, M ;
Castelli, L ;
Mesturini, R ;
Bensi, T ;
Mazzarino, MC ;
Giordano, M ;
D'Alfonso, S ;
Momigliano-Richiardi, P ;
Liguori, M ;
Zorzon, M ;
Amoroso, A ;
Trojano, M ;
Monaco, F ;
Leone, M ;
Magnani, C ;
Dianzani, U .
JOURNAL OF NEUROIMMUNOLOGY, 2005, 163 (1-2) :172-178
[4]   Research criteria for the diagnosis of Alzheimer"s disease: revising the NINCDS-ADRDA criteria [J].
Dubois, Bruno ;
Feldman, Howard H. ;
Jacova, Claudia ;
Dekosky, Steven T. ;
Barberger-Gateau, Pascale ;
Cummings, Jeffrey ;
Delocourte, Andre ;
Galasko, Douglas ;
Gauthier, Serge ;
Jicha, Gregory ;
Meguro, Kenichi ;
O'Brien, John ;
Pasquier, Florence ;
Robert, Philippe ;
Rossor, Martin ;
Solloway, Steven ;
Stern, Yaakov ;
Visser, Pieter J. ;
Scheltens, Philip .
LANCET NEUROLOGY, 2007, 6 (08) :734-746
[5]   MINI-MENTAL STATE - PRACTICAL METHOD FOR GRADING COGNITIVE STATE OF PATIENTS FOR CLINICIAN [J].
FOLSTEIN, MF ;
FOLSTEIN, SE ;
MCHUGH, PR .
JOURNAL OF PSYCHIATRIC RESEARCH, 1975, 12 (03) :189-198
[6]   Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease [J].
Galimberti, D ;
Schoonenboom, N ;
Scheltens, P ;
Fenoglio, C ;
Bouwman, F ;
Venturelli, E ;
Guidi, I ;
Blankenstein, MA ;
Bresolin, N ;
Scarpini, E .
ARCHIVES OF NEUROLOGY, 2006, 63 (04) :538-543
[7]   Intrathecal levels of IL-6, IL-11 and LIF in Alzheimer's disease and frontotemporal lobar degeneration [J].
Galimberti, Daniela ;
Venturelli, Eliana ;
Fenoglio, Chiara ;
Guidi, Ilaria ;
Villa, Chiara ;
Bergamaschini, Luigi ;
Cortini, Francesca ;
Scalabrini, Diego ;
Baron, Pierluigi ;
Vergani, Carlo ;
Bresolin, Nereo ;
Scarpini, Elio .
JOURNAL OF NEUROLOGY, 2008, 255 (04) :539-544
[8]   Osteopontin-induced relapse and progression of autoimmune brain disease through enhanced survival of activated T cells [J].
Hur, Eun Mi ;
Youssef, Sawsan ;
Haws, M. Edward ;
Zhang, Susan Y. ;
Sobel, Raymond A. ;
Steinman, Lawrence .
NATURE IMMUNOLOGY, 2007, 8 (01) :74-83
[9]   Osteopontin expression in substantia nigra in MPTP-treated primates and in Parkinson's disease [J].
Iczkiewicz, Joanna ;
Jackson, Michael J. ;
Smith, Lance A. ;
Rose, Sarah ;
Jenner, Peter .
BRAIN RESEARCH, 2006, 1118 :239-250
[10]   NEURO-IMMUNE CROSSTALK IN CNS DISEASES [J].
Kerschensteiner, M. ;
Meinl, E. ;
Hohlfeld, R. .
NEUROSCIENCE, 2009, 158 (03) :1122-1132